|
AU4701696A
|
|
Monoclonal antibody to herpes simplex virus and cell line producing same
|
|
WO9726329A1
|
|
Monoclonal antibody to herpes simplex virus and cell line producing same
|
|
US5506132A
|
|
Human antibodies against varicella-zoster virus
|
|
US5354772A
|
|
Indole analogs of mevalonolactone and derivatives thereof
|
|
US5321016A
|
|
Use of certain substituted α-amino acids in treating stress-related psychiatric disorders
|
|
PH31164A
|
|
5-Hetero -or aryl-substituted-imidazoÄ2,1AÜisoquinolines.
|
|
US5141932A
|
|
5-Aryl-substituted-2,3-dihydro-imidazo(1,2-a)furo- and thieno pyridines
|
|
US5030632A
|
|
Low dose temazepam
|
|
US4992428A
|
|
5-aryl-substituted-2,3-dihydro-imidazo[1,2-a]furo- and thieno pyridines
|
|
US4925851A
|
|
2- or 4-substituted-[2-(1H-imidazol-1-yl)ethyl]piperidines
|
|
US4973704A
|
|
Pyrrolyl intermediates in the synthesis of pyrrole analogs of mevalonolactone and derivatives thereof
|
|
US4914096A
|
|
6-aryl-substituted-4H-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)diazepines
|
|
US4939159A
|
|
Azaindole derivatives useful as cholesterol biosynthesis inhibitors
|
|
US4910206A
|
|
5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists
|
|
US4927851A
|
|
Analogs of mevalonolactone and derivatives thereof
|
|
US5010067A
|
|
Triglyceride-water emulsion pharmaceutical vehicles
|
|
US5001255A
|
|
Idene analogs of mevalonolactone and derivatives thereof
|
|
US4933105A
|
|
Process for preparation of microspheres
|
|
US4871546A
|
|
Gastrointestinal protective coating formulations
|
|
US4845129A
|
|
Diaryl substituted cyclopentane and cyclopentene derivatives
|
